Moderna Inc (MRNA)

$59.75 -0.67 (-1.11%)
Market Cap 23.97B
Revenue (ttm) 1.94B
Net Income (ttm) -2.82B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -145.16%
Debt to Equity Ratio 0.08
Volume 6,798,700
Avg Vol 7,458,048
Day's Range N/A - N/A
Shares Out 396.79M
Stochastic %K 56%
Beta 1.05
Analysts Hold
Price Target $47.14

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseas...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
maildriver
maildriver Jun. 25 at 11:29 PM
$MRNA started a new position today 100 @ 58.25
0 · Reply
IndyOne
IndyOne Jun. 25 at 8:06 PM
$MRNA Pretty clear what institutions were doing the last 28 minutes of the day. Kind of like a giant grab of all available shares on the table. Some would call this robbery or a heist. I would call it stock trading. Buy and hold.
0 · Reply
Tonqueen
Tonqueen Jun. 25 at 7:46 PM
$MRNA honestly nice consolidation
0 · Reply
KY3000
KY3000 Jun. 25 at 7:27 PM
$MRNA in vivo cart 007, that’s the one to watch, the NHP slides got alot of ppl attention
0 · Reply
IndyOne
IndyOne Jun. 25 at 6:54 PM
$MRNA I have a bot running daily on Moderna jobs. Hiring activity was dropping or flat through late 2025. January 2026 through May 2026 is best described as flat or low. In June, there is a noticeable increase in the number of jobs posted. Today's run is a little unusual with 10 new postings. Bottom line: we should have another upward surprise in this quarter's earnings - great cost control! The increase in new jobs in June is also a clear, bright signal that the commercialization plans are not theory but real. The 4 major commercialization plans are now in process. Likely great earnings this quarter AND more information on new growth, possible Moderna upgrade in revenue growth. I'll post today's "activity" with classification and dates in the comment below - will not fit here. Look at where hiring is occuring. VERY
2 · Reply
cobraglenn
cobraglenn Jun. 25 at 5:36 PM
$MRNA well just been buying a little more on these dips. Hopefully a break even close for the day.
0 · Reply
JFDI
JFDI Jun. 25 at 5:27 PM
$MRNA up and off the 10d
0 · Reply
mj6534
mj6534 Jun. 25 at 5:11 PM
$MRNA of course I buy puts on this POS when it looks like it’s about to plummet and we get these stupid scam pumps. So glad I follow a very popular discord user and took his alert lol 
1 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Jun. 25 at 4:51 PM
$MRNA 🤡
0 · Reply
discussionbo7
discussionbo7 Jun. 25 at 4:44 PM
$SLS $MRNA $TEM hold on to your shares
1 · Reply
Latest News on MRNA
Moderna Transcript: Science Day 2026

Jun 25, 2026, 9:00 AM EDT - 14 hours ago

Moderna Transcript: Science Day 2026

Moderna Slides: FY 2026

Jun 25, 2026, 9:00 AM EDT - 14 hours ago

Moderna Slides: FY 2026

Moderna Science Day highlights potential of mRNA platform

2026-06-25T11:11:06.000Z - 16 hours ago

Moderna Science Day highlights potential of mRNA platform

Moderna Science Day Highlights Expanding Potential of mRNA Platform

Jun 25, 2026, 7:00 AM EDT - 16 hours ago

Moderna Science Day Highlights Expanding Potential of mRNA Platform

FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine

Jun 18, 2026, 4:23 PM EDT - 7 days ago

FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine

Moderna announces FDA advisory committee votes in favor of mRNA-1010

2026-06-18T20:05:10.000Z - 7 days ago

Moderna announces FDA advisory committee votes in favor of mRNA-1010

Moderna up 4% after FDA advisers back flu vaccine approval

2026-06-18T20:01:28.000Z - 7 days ago

Moderna up 4% after FDA advisers back flu vaccine approval

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

Jun 18, 2026, 4:00 PM EDT - 7 days ago

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

Jefferies’ confidence in Moderna’s mRNA flu shot rises after AdCom support

2026-06-18T19:40:11.000Z - 7 days ago

Jefferies’ confidence in Moderna’s mRNA flu shot rises after AdCom support

US FDA advisers vote in favor of Moderna's flu vaccine

Jun 18, 2026, 2:48 PM EDT - 7 days ago

US FDA advisers vote in favor of Moderna's flu vaccine

FDA panel backs Moderna mRNA-based influenza vaccine, Bloomberg reports

2026-06-18T18:45:10.000Z - 7 days ago

FDA panel backs Moderna mRNA-based influenza vaccine, Bloomberg reports

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

Jun 18, 2026, 6:01 AM EDT - 7 days ago

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

Moderna to Host Investor Event - Science Day

Jun 17, 2026, 7:00 AM EDT - 8 days ago

Moderna to Host Investor Event - Science Day

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

Jun 17, 2026, 2:38 AM EDT - 8 days ago

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

BNTX

BofA says VRBPAC docs look supportive but keeps Moderna at Underperform

2026-06-16T16:05:26.000Z - 9 days ago

BofA says VRBPAC docs look supportive but keeps Moderna at Underperform

FDA posts briefing docs for meeting to discuss Moderna influenza vaccine

2026-06-16T13:24:19.000Z - 9 days ago

FDA posts briefing docs for meeting to discuss Moderna influenza vaccine

Moderna flu vaccine briefing docs ‘read favorably,’ says Jefferies

2026-06-16T13:21:09.000Z - 9 days ago

Moderna flu vaccine briefing docs ‘read favorably,’ says Jefferies

US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults

Jun 16, 2026, 9:12 AM EDT - 9 days ago

US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults

Moderna announces executive changes ahead of potential launches

Jun 16, 2026, 8:37 AM EDT - 9 days ago

Moderna announces executive changes ahead of potential launches

Moderna president Stephen Hoge to assume expanded role, Ester Banque named CCO

2026-06-16T11:40:13.000Z - 9 days ago

Moderna president Stephen Hoge to assume expanded role, Ester Banque named CCO

ZTS

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

Jun 16, 2026, 7:30 AM EDT - 9 days ago

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

Moderna Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 3:20 PM EDT - 16 days ago

Moderna Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

Jun 8, 2026, 7:01 PM EDT - 17 days ago

Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

Moderna price target raised to $34 from $32 at BofA

2026-06-08T10:52:26.000Z - 17 days ago

Moderna price target raised to $34 from $32 at BofA

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Jun 3, 2026, 8:10 AM EDT - 22 days ago

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

AES ARW BAX EXP EXPD HPQ IESC

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”

Jun 2, 2026, 4:34 PM EDT - 23 days ago

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”

Moderna to Present at Upcoming Conference in June 2026

Jun 2, 2026, 7:00 AM EDT - 23 days ago

Moderna to Present at Upcoming Conference in June 2026

Moderna Transcript: Study update

Jun 1, 2026, 7:15 PM EDT - 24 days ago

Moderna Transcript: Study update

Moderna Press release: Study update

Jun 1, 2026, 7:15 PM EDT - 24 days ago

Moderna Press release: Study update

Moderna Slides: Study update

Jun 1, 2026, 7:15 PM EDT - 24 days ago

Moderna Slides: Study update

Moderna, Merck to present 5-year data for intismeran autogene

2026-06-01T15:16:30.000Z - 24 days ago

Moderna, Merck to present 5-year data for intismeran autogene

MRK

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Jun 1, 2026, 8:00 AM EDT - 24 days ago

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

MRK

Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine

Jun 1, 2026, 5:37 AM EDT - 24 days ago

Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine

Moderna expands pact with CEPI to advance potential vaccine against BDBV

2026-06-01T09:05:43.000Z - 24 days ago

Moderna expands pact with CEPI to advance potential vaccine against BDBV

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Jun 1, 2026, 5:00 AM EDT - 24 days ago

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Moderna Transcript: Bernstein 42nd Annual Strategic Decisions Conference

May 28, 2026, 10:00 AM EDT - 4 weeks ago

Moderna Transcript: Bernstein 42nd Annual Strategic Decisions Conference

Moderna, Merck cancer combo cuts melanoma spread risk at five years

May 21, 2026, 5:03 PM EDT - 5 weeks ago

Moderna, Merck cancer combo cuts melanoma spread risk at five years

MRK

US FDA to hold expert committee meeting to review Moderna's flu vaccine

May 21, 2026, 11:26 AM EDT - 5 weeks ago

US FDA to hold expert committee meeting to review Moderna's flu vaccine

FDA to hold advisory hearing to debate Moderna’s flu vaccine, Bloomberg reports

2026-05-21T15:20:30.000Z - 5 weeks ago

FDA to hold advisory hearing to debate Moderna’s flu vaccine, Bloomberg reports

Moderna Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 19, 2026, 10:00 AM EDT - 5 weeks ago

Moderna Transcript: RBC Capital Markets Global Healthcare Conference 2026

Moderna Recognized by TIME as One of the World's Most Impactful Companies

May 12, 2026, 5:00 PM EDT - 6 weeks ago

Moderna Recognized by TIME as One of the World's Most Impactful Companies

Moderna Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 2:20 PM EDT - 6 weeks ago

Moderna Transcript: Bank of America Global Healthcare Conference 2026

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

May 12, 2026, 1:25 PM EDT - 6 weeks ago

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

Hantavirus outbreak: these 3 stocks are poised to rip higher

May 11, 2026, 11:44 PM EDT - 6 weeks ago

Hantavirus outbreak: these 3 stocks are poised to rip higher

MMM QDEL

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.

May 11, 2026, 8:19 PM EDT - 6 weeks ago

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

May 11, 2026, 1:17 PM EDT - 6 weeks ago

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

Moderna stock soars as hantavirus fears spark outbreak trade

May 11, 2026, 10:44 AM EDT - 6 weeks ago

Moderna stock soars as hantavirus fears spark outbreak trade

Hantavirus cases spark surge in pharma and biotech stocks — here's why

May 11, 2026, 7:53 AM EDT - 6 weeks ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO NVAX

Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive.

May 11, 2026, 5:29 AM EDT - 6 weeks ago

Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive.

How Hantavirus Made Moderna a Must-Own Stock Again

May 8, 2026, 2:44 PM EDT - 6 weeks ago

How Hantavirus Made Moderna a Must-Own Stock Again

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

May 6, 2026, 5:15 PM EDT - 7 weeks ago

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

May 6, 2026, 5:01 PM EDT - 7 weeks ago

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

Moderna Transcript: AGM 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Moderna Transcript: AGM 2026

Moderna Earnings Call Transcript: Q1 2026

May 1, 2026, 8:00 AM EDT - 7 weeks ago

Moderna Earnings Call Transcript: Q1 2026

Moderna Slides: Q1 2026

May 1, 2026, 8:00 AM EDT - 7 weeks ago

Moderna Slides: Q1 2026

Moderna Quarterly report: Q1 2026

May 1, 2026, 8:00 AM EDT - 7 weeks ago

Moderna Quarterly report: Q1 2026

Moderna Earnings release: Q1 2026

May 1, 2026, 8:00 AM EDT - 7 weeks ago

Moderna Earnings release: Q1 2026

Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.

May 1, 2026, 7:46 AM EDT - 7 weeks ago

Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.

Moderna Reports Higher Revenue but Posts a Loss

May 1, 2026, 6:37 AM EDT - 7 weeks ago

Moderna Reports Higher Revenue but Posts a Loss

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

May 1, 2026, 6:32 AM EDT - 7 weeks ago

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

May 1, 2026, 6:30 AM EDT - 7 weeks ago

Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

CureVac sues Moderna for patent infringement over COVID-19 vaccines

Apr 24, 2026, 4:52 PM EDT - 2 months ago

CureVac sues Moderna for patent infringement over COVID-19 vaccines

CVAC

Moderna starts late-stage trial of bird flu vaccine in US, UK

Apr 21, 2026, 7:13 PM EDT - 2 months ago

Moderna starts late-stage trial of bird flu vaccine in US, UK

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

Apr 21, 2026, 7:01 PM EDT - 2 months ago

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting

Apr 21, 2026, 10:00 AM EDT - 2 months ago

Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting

Moderna wins EU approval for combined flu, COVID shot for older adults

Apr 21, 2026, 9:59 AM EDT - 2 months ago

Moderna wins EU approval for combined flu, COVID shot for older adults

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Apr 21, 2026, 9:40 AM EDT - 2 months ago

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Moderna to Present at Upcoming Conferences in May 2026

Apr 21, 2026, 7:00 AM EDT - 2 months ago

Moderna to Present at Upcoming Conferences in May 2026

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

Apr 17, 2026, 3:00 PM EDT - 2 months ago

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026

Apr 15, 2026, 7:00 AM EDT - 2 months ago

Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

Apr 6, 2026, 6:01 PM EDT - 2 months ago

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

Moderna Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 3 months ago

Moderna Proxy statement: Proxy Filing

Moderna Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 3 months ago

Moderna Proxy statement: Proxy Filing

Moderna Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 9:30 AM EDT - 3 months ago

Moderna Transcript: Barclays 28th Annual Global Healthcare Conference

FDA reversals leave investors worrying about the fates of other experimental drugs

Mar 6, 2026, 11:33 AM EST - 3 months ago

FDA reversals leave investors worrying about the fates of other experimental drugs

DNLI RGNX WVE

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Mar 4, 2026, 8:26 AM EST - 4 months ago

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Mar 4, 2026, 5:25 AM EST - 4 months ago

Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Mar 3, 2026, 5:30 PM EST - 4 months ago

Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

Mar 3, 2026, 4:46 PM EST - 4 months ago

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

ABUS

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

Mar 3, 2026, 4:26 PM EST - 4 months ago

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

ABUS ROIV

maildriver
maildriver Jun. 25 at 11:29 PM
$MRNA started a new position today 100 @ 58.25
0 · Reply
IndyOne
IndyOne Jun. 25 at 8:06 PM
$MRNA Pretty clear what institutions were doing the last 28 minutes of the day. Kind of like a giant grab of all available shares on the table. Some would call this robbery or a heist. I would call it stock trading. Buy and hold.
0 · Reply
Tonqueen
Tonqueen Jun. 25 at 7:46 PM
$MRNA honestly nice consolidation
0 · Reply
KY3000
KY3000 Jun. 25 at 7:27 PM
$MRNA in vivo cart 007, that’s the one to watch, the NHP slides got alot of ppl attention
0 · Reply
IndyOne
IndyOne Jun. 25 at 6:54 PM
$MRNA I have a bot running daily on Moderna jobs. Hiring activity was dropping or flat through late 2025. January 2026 through May 2026 is best described as flat or low. In June, there is a noticeable increase in the number of jobs posted. Today's run is a little unusual with 10 new postings. Bottom line: we should have another upward surprise in this quarter's earnings - great cost control! The increase in new jobs in June is also a clear, bright signal that the commercialization plans are not theory but real. The 4 major commercialization plans are now in process. Likely great earnings this quarter AND more information on new growth, possible Moderna upgrade in revenue growth. I'll post today's "activity" with classification and dates in the comment below - will not fit here. Look at where hiring is occuring. VERY
2 · Reply
cobraglenn
cobraglenn Jun. 25 at 5:36 PM
$MRNA well just been buying a little more on these dips. Hopefully a break even close for the day.
0 · Reply
JFDI
JFDI Jun. 25 at 5:27 PM
$MRNA up and off the 10d
0 · Reply
mj6534
mj6534 Jun. 25 at 5:11 PM
$MRNA of course I buy puts on this POS when it looks like it’s about to plummet and we get these stupid scam pumps. So glad I follow a very popular discord user and took his alert lol 
1 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Jun. 25 at 4:51 PM
$MRNA 🤡
0 · Reply
discussionbo7
discussionbo7 Jun. 25 at 4:44 PM
$SLS $MRNA $TEM hold on to your shares
1 · Reply
SteweiGriffin
SteweiGriffin Jun. 25 at 4:34 PM
$MRNA I see dumping no buying and low volume too, I think this is going below 50 soon, who ever bought puts congrats
0 · Reply
AlphaTrader8
AlphaTrader8 Jun. 25 at 3:57 PM
$MRNA Pump is over unfortunately $QQQ $SPY $PLTR $MU
1 · Reply
Galba
Galba Jun. 25 at 3:47 PM
$MRNA With this news behind us, the news I’m hoping to see is next years data on mRNA 2808(personal reasons) but like most cancer treatments I’ve been involved with, it takes time. I’ve plateaued on a few treatments after > 1yr. These treatments sound and I hope, end up successful. I’m very encouraged by today’s Science Day. There’s a lot of promise but as for the stock today, I don’t know, not anything definitive till August. GLTA
0 · Reply
ccccccd
ccccccd Jun. 25 at 3:46 PM
$MRNA losing to XBI !!!!!!lets go
0 · Reply
SteweiGriffin
SteweiGriffin Jun. 25 at 3:43 PM
$MRNA I am becoming binpolar with this stock
0 · Reply
ccccccd
ccccccd Jun. 25 at 3:34 PM
$MRNA double confirm bull trap is insane~
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 25 at 3:29 PM
$MRNA be like
0 · Reply
SteweiGriffin
SteweiGriffin Jun. 25 at 3:25 PM
$MRNA WTF really?? Such good data and this is not miving at all
2 · Reply
SteweiGriffin
SteweiGriffin Jun. 25 at 3:12 PM
$MRNA Should be 63-64 by now
0 · Reply
KY3000
KY3000 Jun. 25 at 2:58 PM
$MRNA invivo car t modality=wow, treatment for MS=wow, all found by LUCY, their AI platform. LFG
0 · Reply
SteweiGriffin
SteweiGriffin Jun. 25 at 2:56 PM
$MRNA Come on 63
0 · Reply
RaymondR3ddington
RaymondR3ddington Jun. 25 at 2:22 PM
$MRNA added new starter😱
0 · Reply